Sort
82,697 grants matching “vaccine development”
TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung
$705,521Ya-Wen Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Vaccine Trial for Influenza
$705,509Emmanuel Walter · Duke University · N01 · FY2019 · AI
The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child
$705,493Anna-Sophie Rommel · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HD
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$705,487Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2023 · AI
Baltimore Acute Hepatitis C Cooperative Center
$705,407Andrea L Cox · Johns Hopkins University · U19 · FY2013 · AI
Alphavirus Vaccines for Biodefense
$705,387Scott C Weaver · University Of Texas Med Br Galveston · U54 · FY2013 · AI
Undetected Drug resistance and Tolerance in lesions of recurrent TB
$705,382Faramarz Valafar · San Diego State University · R01 · FY2022 · AI
Chronic Wasting Disease Vaccines
$705,343Candace K. Mathiason · Colorado State University · R01 · FY2024 · AI
Antibody Maturation Elicited by Integrase Defective Lentiviral Vectors
$705,314Michael Anthony Moody · Duke University · P01 · FY2018 · AI
Proteogenomics of dysregulated protein interaction networks in MTB infection
$705,283W. Henry Henry Boom · Case Western Reserve University · R01 · FY2011 · HL
Impact of a SARS-CoV-2 vaccine on gut integrity, immune activation and efficacy of ART
$705,280Cristian Apetrei · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Conjugate vaccine impact on pneumococcal carriage, disease, and population geneti
$705,263Jonathan A Finkelstein · Harvard Pilgrim Health Care, Inc. · R01 · FY2013 · AI
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry
$705,245Richard M Longnecker · Northwestern University At Chicago · R01 · FY2020 · AI
Regulatory Compliance Core - Galveston National Laboratory BSL4 Operations
$705,217David Beasley · University Of Texas Med Br Galveston · UC7 · FY2017 · AI
Developmental Projects
$705,179Dennis L. Kasper · Harvard Medical School · U54 · FY2009 · AI
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$705,162Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome
$705,129Julie Dunning Hotopp · University Of Maryland Baltimore · R01 · FY2019 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$705,120Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Chronic Wasting Disease Vaccines
$705,042Candace K. Mathiason · Colorado State University · R01 · FY2025 · AI
A universal malaria T cell vaccine based on HLA-E presentation
$705,028Brandon Keith Wilder · Oregon Health & Science University · R01 · FY2024 · AI
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
$705,012David Serre · University Of Maryland Baltimore · R01 · FY2024 · AI
Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
$704,939Peter Rice · Univ Of Massachusetts Med Sch Worcester · N01 · FY2022 · AI
Core B: Data Management and Analysis
$704,936Steven H. Kleinstein · Yale University · U19 · FY2019 · AI
COVID-19 vaccine in naive individuals and cancer patients
$704,873Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Examining IL-15 as an immunotherapy agent in cancer and AIDS
$704,873Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA